2seventy bio, Inc. (TSVT)
Company Info
| ISIN | US9013841070 |
|---|---|
| CUSIP | 901384107 |
| Sector | Healthcare |
| Industry | Drug Manufacturers—General |
Highlights
| Market Cap | $218.33M |
|---|---|
| EPS | -$4.42 |
| PE Ratio | 28.40 |
| PEG Ratio | 2.18 |
| Revenue (TTM) | $100.39M |
| Gross Profit (TTM) | -$183.46M |
| EBITDA (TTM) | -$206.42M |
| Year Range | $1.54 - $12.69 |
| Target Price | $11.00 |
| Short % | 12.78% |
| Short Ratio | 4.06 |
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Popular comparisons: TSVT vs. VOO
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in 2seventy bio, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
2seventy bio, Inc. had a return of 7.73% year-to-date (YTD) and -54.81% in the last 12 months.
| Period | Return | Benchmark |
|---|---|---|
| Year-To-Date | 7.73% | 5.21% |
| 1 month | -20.55% | -4.30% |
| 6 months | 97.42% | 18.42% |
| 1 year | -54.81% | 21.82% |
| 5 years (annualized) | N/A | 11.27% |
| 10 years (annualized) | N/A | 10.33% |
Monthly Returns Heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 20.37% | 1.17% | 2.88% | -14.77% | ||||||||
| 2023 | -37.76% | -25.00% | 133.33% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of TSVT is 22, indicating that it is in the bottom 22% of the market in terms of risk-adjusted performance. This ranking is based on the combined values of the indicators listed below.
2seventy bio, Inc.(TSVT)
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for 2seventy bio, Inc. (TSVT) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the 2seventy bio, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the 2seventy bio, Inc. was 96.31%, occurring on Nov 21, 2023. The portfolio has not yet recovered.
The current 2seventy bio, Inc. drawdown is 89.19%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -96.31% | Nov 10, 2021 | 511 | Nov 21, 2023 | — | — | — |
Volatility
Volatility Chart
The current 2seventy bio, Inc. volatility is 23.81%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Income Statement
| TTM | |
|---|---|
| Revenue | |
Total Revenue | 0.00 |
Cost Of Revenue | 0.00 |
Gross Profit | 0.00 |
| Operating Expenses | |
Selling, General & Admin Expenses | 0.00 |
R&D Expenses | 0.00 |
Total Operating Expenses | 0.00 |
| Income | |
Income Before Tax | 0.00 |
Operating Income | 0.00 |
EBIT | 0.00 |
Earnings From Continuing Operations | 0.00 |
Net Income | 0.00 |
Income Tax Expense | 0.00 |
Interest Expense | 0.00 |
Other Non-Operating Income (Expenses) | 0.00 |
Extraordinary Items | 0.00 |
Discontinued Operations | 0.00 |
Effect Of Accounting Charges | 0.00 |
Non Recurring | 0.00 |
Minority Interest | 0.00 |
Other Items | 0.00 |